iTBra consists of two comfortable and intelligent patches, worn underneath your garments, which detect circadian temperature changes in breast tissue. Anonymised data is communicated directly to the Cyrcadia’s core lab for analysis via your mobile device. Results are sent back to you within minutes.
The iTBra empowers women to monitor their own breast health, and detects breast cancer at its earliest possible stages.
Accessible
Easy to use, even in your own home and going about your daily routine, an early breast health monitoring system.
Comfortable
No pressing. No pain. No radiation. No uncomfortable examinations.
Convenient
Discrete monthly wear anywhere, anytime.
Early detection means less biopsies & more lives saved
Listed as one of the Top 40 Medical Transformers for 2016 by Medical Marketing and Management Magazine. Led global efforts of both public and private venture technologies, with demonstrated successes from start-up to over $550M. Positioned Cyrcadia to earn the prestigious Edison award in 2016 as the #1 company in Health and Wellness, Wearable and Sensors Category.
Specialised in corporate mergers, acquisitions and restructurings in NZ, Australia, USA, UK and China. Brings over 20 years experience advising and investing in China, during which time he has helped to found several companies and has advised a number of Chinese companies on their international acquisitions.
Chris’ professional experience includes acting as an Executive with the IP specialist firm, Rouse (www.rouse.com). Chris brings 18 years of experience in advising overseas companies on the management, protection and commercialisation of their IP assets in China and other countries in Asia.
M.D. & Ph.D. in Molecular Pharmacology from Albert Einstein College of Medicine. Specializes in surgical oncology for the treatment breast, melanoma, colon, stomach, liver and pancreatic cancer.
Ph.D. in Biomedical Engineering at Nanyang Technological University of Singapore. Brings 10+ years of experience in the medical analytics field, in applied predictive algorithms for the detection of cancers in the breast, ovaries, prostate and thyroid.
Strong background in media and healthcare transactions in China including the formation of Yuxin Media and Cyrcadia Asia.
PhD in business administration and an MBA. Formerly a senior partner at McKinsey with over 10 years of experience in the Asian healthcare and health insurance sectors, leading McKinsey’s China Healthcare Sector team and its Asian Health Services and Systems team until stepping down in 2016. Is currently a Director of Roche AG and Clariant AG.
Listed as one of the Top 40 Medical Transformers for 2016 by Medical Marketing and Management Magazine. Led global efforts of both public and private venture technologies, with demonstrated successes from start-up to over $550M. Positioned Cyrcadia to earn the prestigious Edison award in 2016 as the #1 company in Health and Wellness, Wearable and Sensors Category.
Specialised in corporate mergers, acquisitions and restructurings in NZ, Australia, USA, UK and China. Brings over 20 years experience advising and investing in China, during which time he has helped to found several companies and has advised a number of Chinese companies on their international acquisitions.
Chris’ professional experience includes acting as an Executive with the IP specialist firm, Rouse (www.rouse.com). Chris brings 18 years of experience in advising overseas companies on the management, protection and commercialisation of their IP assets in China and other countries in Asia.
M.D. & Ph.D. in Molecular Pharmacology from Albert Einstein College of Medicine. Specializes in surgical oncology for the treatment breast, melanoma, colon, stomach, liver and pancreatic cancer.
Ph.D. in Biomedical Engineering at Nanyang Technological University of Singapore. Brings 10+ years of experience in the medical analytics field, in applied predictive algorithms for the detection of cancers in the breast, ovaries, prostate and thyroid.
Strong background in media and healthcare transactions in China including the formation of Yuxin Media and Cyrcadia Asia.
PhD in business administration and an MBA. Formerly a senior partner at McKinsey with over 10 years of experience in the Asian healthcare and health insurance sectors, leading McKinsey’s China Healthcare Sector team and its Asian Health Services and Systems team until stepping down in 2016. Is currently a Director of Roche AG and Clariant AG.
Empowering women with early detection
We use predictive AI technology for early and
accurate breast cancer detection.